Top Markets
#1 Islamic Coin Islamic Coin +154.46%
#2 PulseChain PulseChain +48.38%
#3 Ergo Ergo +29.15%
#4 Not in Employment, Education, or Training Not in Employment, Education, or Training +16.40%
#5 RedStone RedStone +16.30%
#6 SkyAI SkyAI +10.37%
#7 Lighter Lighter +9.20%
#8 OPENLOOT OPENLOOT +8.93%
#9 Siren Siren +8.92%
#10 MarsCoin MarsCoin +8.84%
Coin of the day
Islamic Coin Islamic Coin
設定
言語
日本
通貨
USD
テーマ
Genenta Science S.p.A. Genenta Science S.p.A.

Genenta Science S.p.A.

GNTA
株式のランク #28070
Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused... Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused on pioneering hematopoietic stem cell gene therapies to combat solid tumors. Its primary therapeutic candidate, Temferon, is currently undergoing Phase 1/2a clinical evaluation. This innovative therapy is being developed to treat glioblastoma multiforme, specifically targeting patients whose tumors exhibit an unmethylated MGMT gene promoter. Beyond this, Genenta Science is exploring Temferon's potential application in various other solid tumor types, including locally advanced hepatocellular carcinoma and intra-hepatic cholangiocarcinoma. Established in 2014, the company maintains its headquarters in Milan, Italy.
株価
$1.51
最終同期: 2026-07-31
時価総額
$28.82M
変化（1日）
-0.33%
変化（1年）
-57.49%
国
IT
取引 Genenta Science S.p.A. (GNTA)

カテゴリー

Healthcare
Genenta Science S.p.A.（GNTA）の配当利回りの履歴
Genenta Science S.p.A.（銘柄コード: GNTA）の配当利回り（TTM）は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Genenta Science S.p.A.（GNTA）の2026から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
年 配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り（TTM）
企業 配当利回り 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH